Table 4. The asymmetry in DVRs for [11C]TMSX and URIs for [11C]CFT and [11C]RAC in the striata of drug-naïve patients with Parkinson's disease.
Radiopharmaceutical | More affected side | Less affected side |
Putamen | ||
[11C]TMSX | 1.46±0.11 | 1.50±0.10* |
[11C]CFT | 0.98±0.30 | 1.29±0.29† |
[11C]RAC | 3.59±0.53 | 3.27±0.56† |
Head of the caudate nucleus | ||
[11C]TMSX | 1.38±0.10 | 1.36±0.08 |
[11C]CFT | 1.78±0.33 | 1.89±0.38 |
[11C]RAC | 2.52±0.37 | 2.47±0.39 |
Values are mean ± SD (PD: n = 9). Binding of [11C]TMSX was evaluated as the distribution volume ratio (DVR) and binding of [11C]CFT or [11C]RAC was expressed as the uptake ratio index (URI).
*p<0.05,
p<0.005 (paired t-test).